Renalytix plc Increase (Decrease) in Accrued Liabilities
Renalytix plc (RENXF) reported Increase (Decrease) in Accrued Liabilities of -$1.31 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2024-11-19
- Renalytix plc increase (decrease) in accrued liabilities for the quarter ending 2024-09-30 was -$1.31M.
- Renalytix plc increase (decrease) in accrued liabilities for the quarter ending 2024-06-30 was -$900.00K, a 229.87% decline year-over-year.
- Renalytix plc increase (decrease) in accrued liabilities for the quarter ending 2024-03-31 was -$54.00K, a 104.04% decline year-over-year.
- Renalytix plc increase (decrease) in accrued liabilities for the quarter ending 2023-12-31 was -$405.00K, a 127.14% decline year-over-year.
- Renalytix plc increase (decrease) in accrued liabilities for fiscal 2024 was -$3.42M, a 200.65% decline from fiscal 2023.
- Renalytix plc increase (decrease) in accrued liabilities for fiscal 2023 was $3.40M.
- Renalytix plc increase (decrease) in accrued liabilities for fiscal 2022 was -$1.50M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 4 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | -$1.31M 10-Q · filed 2024-11-19 | -$2.21M derived: sum of 2 quarters · filed 2024-11-19 | -$2.27M derived: sum of 3 quarters · filed 2024-11-19 | -$2.67M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2024-06-30 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$954.00K derived: sum of 2 quarters · filed 2024-09-30 | -$1.36M derived: sum of 3 quarters · filed 2024-09-30 | -$3.42M 10-K · filed 2024-09-30 | |
| 2024-03-31 | -$54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$459.00K derived: sum of 2 quarters · filed 2024-05-15 | -$2.52M 10-Q · filed 2024-05-15 | -$1.83M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2023-12-31 | -$405.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$2.46M 10-Q · filed 2024-02-14 | -$1.77M derived: sum of 3 quarters · filed 2024-11-19 | -$435.00K derived: sum of 4 quarters · filed 2024-11-19 | |
| 2023-09-30 | -$2.06M 10-Q · filed 2024-11-19 | -$1.37M derived: sum of 2 quarters · filed 2024-11-19 | -$30.00K derived: sum of 3 quarters · filed 2024-11-19 | $1.46M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2023-06-30 | $693.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $2.03M derived: sum of 2 quarters · filed 2024-09-30 | $3.52M derived: sum of 3 quarters · filed 2024-09-30 | $3.40M 10-K · filed 2024-09-30 | |
| 2023-03-31 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $2.83M derived: sum of 2 quarters · filed 2024-05-15 | $2.70M 10-Q · filed 2024-05-15 | -$892.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $1.37M 10-Q · filed 2024-02-14 | -$2.23M derived: sum of 3 quarters · filed 2024-02-14 | $166.00K derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | -$125.00K 10-Q · filed 2023-11-14 | -$3.72M derived: sum of 2 quarters · filed 2023-11-14 | -$1.33M derived: sum of 3 quarters · filed 2023-11-14 | -$1.64M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$3.60M derived: 10-K 12 month − 6-K 9 month · filed 2023-09-28 | -$1.20M derived: sum of 2 quarters · filed 2023-09-28 | -$1.52M derived: sum of 3 quarters · filed 2023-09-28 | -$1.50M 10-K · filed 2023-09-28 | |
| 2022-03-31 | $2.40M derived: 6-K 9 month − 6-K 6 month · filed 2023-06-09 | $2.08M derived: sum of 2 quarters · filed 2023-06-09 | $2.09M 6-K · filed 2023-06-09 | $3.95M derived: sum of 4 quarters · filed 2023-06-09 | |
| 2021-12-31 | -$318.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-03-30 | -$304.00K 6-K · filed 2023-03-30 | $1.56M derived: sum of 3 quarters · filed 2023-03-30 | $2.71M derived: sum of 4 quarters · filed 2023-03-30 | |
| 2021-09-30 | $14.00K 6-K · filed 2022-11-30 | $1.88M derived: sum of 2 quarters · filed 2022-11-30 | $3.02M derived: sum of 3 quarters · filed 2022-11-30 | ||
| 2021-06-30 | $1.86M derived: 20-F 12 month − 6-K 9 month · filed 2022-10-31 | $3.01M derived: sum of 2 quarters · filed 2022-10-31 | $4.35M 20-F · filed 2022-10-31 | ||
| 2021-03-31 | $1.15M derived: 6-K 9 month − 6-K/A 6 month · filed 2022-06-30 | $2.49M 6-K · filed 2022-06-30 | |||
| 2020-12-31 | $1.34M 6-K/A · filed 2022-04-29 | ||||
| 2020-06-30 | -$456.00K 20-F · filed 2022-10-31 | ||||
| 2019-06-30 | $221.00K 20-F/A · filed 2022-08-01 | ||||
| 2018-06-30 | $170.00K 20-F/A · filed 2020-11-10 |